Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Investigation|January 12, 2018
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA networkXiaochao Tan, Priyam Banerjee, Xin Liu, et al.
Cancer Research|March 22, 2012
AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancerYon Hui Kim, Han Liang, Xiuping Liu, et al.
Nature|May 3, 2013
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2Jia Shen, Weiya Xia, Yekaterina B Khotskaya, et al.
Gut|November 21, 2014
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancerHae Ryung Chang, Seungyoon Nam, Myeong-Cherl Kook, et al.
The Journal of Clinical Investigation|January 10, 2013
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastomaBrittany C Parker, Matti J Annala, David E Cogdell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
The Journal of Clinical Investigation|June 1, 2022
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancersZhen Lu, Weiqun Mao, Hailing Yang, et al.
Cancer Research|November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by RadiotherapyXiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.
Nature Medicine|August 15, 2017
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activationPingzhao Zhang, Dejie Wang, Yu Zhao, et al.
The EPMA Journal|March 11, 2024
Cancer screening in hospitalized ischemic stroke patients: a multicenter study focused on multiparametric analysis to improve management of occult cancersJie Fang, Jielong Wu, Ganji Hong, et al.
Pageof 25